10 results · 18ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

CLARAVUE Pre-wired Electrode - IP SET M5 RT ADULT-US Model: 32028778 50601-US

FDA Enforcement
Class II ·Terminated·Graphic Controls Acquisition Corporation·April 20, 2022

CLARAVUE Pre-wired Electrode - IP SET M3 RT ADULT-US Model: 32028777 50600 US

FDA Enforcement
Class II ·Terminated·Graphic Controls Acquisition Corporation·April 20, 2022

CLARAVUE Pre-wired Electrode - IP SET 6V RT ADULT-US Model: 32028780 50603-US

FDA Enforcement
Class II ·Terminated·Graphic Controls Acquisition Corporation·April 20, 2022

CLARAVUE Pre-wired Electrode - IP SET 12 RT ADULT-US Model: 32028779 50602-US

FDA Enforcement
Class II ·Terminated·Graphic Controls Acquisition Corporation·April 20, 2022

CLARAVUE Pre-wired Electrode IP-SET N3 - PEDIATRIC-US Model: 32028776 50401-US

FDA Enforcement
Class II ·Terminated·Graphic Controls Acquisition Corporation·April 20, 2022

CLARAVUE Pre-wired Electrode - IP SET 5V RT ADULT Model: 32028781 50604-US

FDA Enforcement
Class II ·Terminated·Graphic Controls Acquisition Corporation·April 20, 2022

KIT, PRE OP DRAH - Product Usage: Preoperative kit used to decolonize intranasal S. aureus.

FDA Recall
Terminated ·Cardinal Health 200, LLC·Product code LRP·July 30, 2020

WIRION EMBOLIC PROTECTION SYSTEM, Delivery Catheter and Filter and Retrieval Catheter, 6Fr, REF (Model Number) WRN-D6

FDA Recall
Terminated ·Cardiovascular Systems Inc·Product code NTE·November 22, 2021

Peripheral Diamondback 1.50 Solid OAD, a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy.

FDA Recall
Terminated ·Cardiovascular Systems Inc·Product code MCW·September 14, 2017

Peripheral Diamondback 1.25 Solid OAD, a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy.

FDA Recall
Terminated ·Cardiovascular Systems Inc·Product code MCW·September 14, 2017